Skip to main content
Eisai Co., Ltd. logo

Eisai Co., Ltd. — Investor Relations & Filings

Ticker · 4523 ISIN · JP3160400002 LEI · 353800HDEE0ZYEX4QV91 T Manufacturing
Filings indexed 76 across all filing types
Latest filing 2015-11-09 Interim / Quarterly Rep…
Country JP Japan
Listing T 4523

About Eisai Co., Ltd.

https://www.eisai.com/index.html

Eisai Co., Ltd. is a research-based global pharmaceutical company engaged in the discovery, development, manufacture, and marketing of prescription medicines. The company's primary business activities are concentrated in the therapeutic areas of neurology, with a significant focus on dementia-related diseases, and oncology. Guided by its core "human health care" (hhc) philosophy, Eisai prioritizes the needs of patients and their families. The company is dedicated to developing innovative and targeted treatments for challenging medical conditions and actively promotes initiatives to improve access to medicines in developing and emerging countries.

Recent filings

Filing Released Lang Actions
四半期報告書-第104期第2四半期(2015/07/01-2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Eisai Co., Ltd. covering the period from July 1, 2015, to September 30, 2015. It contains detailed financial statements, management analysis of business performance, and financial indicators, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2016
2015-11-09 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.